Jennifer was born to a young Chicago couple, and grew into a beautiful long-lashed child with wavy dark hair, big brown eyes and a yearning, youthful desire to be just like all other girls, but she wasn’t.
Firstly doctors noticed her slightly enlarged genitals, and then discovered that she had testes inside her abdomen and male chromosomes. They started a series of surgeries to make things ‘right’.
Sandoz, a Novartis company, announced that the United States Food and Drug Administration (FDA) has approved its Glatopa, which the first generic alternative version for Teva Pharmaceutical's multiple sclerosis treatment Copaxone. According to reports, Glatopa has been approved as treatment for multiple sclerosis.
Risks associated with consumption of sugary beverages have been discussed in many previous studies. It has been found in most of the studies that these beverages increase the risk of many health conditions or make previously existing ones worse.
A new study, which has been published in the Journal of Clinical Endocrinology & Metabolism, has seen the issue from a different point.
A kid has raised more than $75,000 to help his father get a kidney transplant. The kid is highly recognized on the internet. The so-called Success Kid made plea with his family last week to provide funding for his father Justin, 39, to get a kidney transplant.
With an aim to improve the industry of precision medicine, California Governor Jerry Brown has announced partnership with the University of California to come up with a local program.
In this program, more partnerships will take place not only at industry level, but also at academic level. Main aim of the California Initiative to Advance Precision Medicine is to find ways to cross-reference patients' medical data with other types of data like mobile, environmental, genomic and socioeconomic.
Amgen's heart-failure treatment Corlanor has got a green signal from the US Food and Drug Administration. The drug was designated for priority review in August.
The drug is believed to have high efficacy of regulating heart rate and reducing the risk of hospitalization for worsening heart failure. The drug is meant for patients with stable, chronic heart failure caused by a poorly-contracting lower-left part of the heart.
Each year, many Americans go to a doctor or a local pharmacy to get at least one shot. The number increases in case of growing children as they are vaccinated for many new and very old illnesses. Rice University researchers are making efforts to make the shots less painful.
A team of freshman engineering students at the school have created a device, which causes a quick chemical reaction to cool a patient's skin before receiving a shot. It has been proved that the device can numb a patient's skin within 60 seconds.
Zircon - This is a contributing Drupal Theme
Design by WeebPal